| Application no. and date | 19765710.9 (espacenet) (Federated) (European Patent Register), 20190906 | | Patent/reg. no. and date | DK/EP 3847156, 20220504 | | Publication date | 20210714 | | Priority no. and date | EP 18306177, 20180907 | | EP pub. no. and date |
EP 3847156 20210714 | | Effective date | | | Applicant/owner | Sanofi, 46 Avenue de la Grande Armée
75017 Paris, FR | | Applicant ref. no. | 1626652 | | Inventor | RUIZ MONTES, José, Sanofi - Patent Department 54 rue La Boétie
75008 Paris, FR,
MALPART, Joël, Sanofi - Patent Department 54 rue La Boétie
75008 Paris, FR | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07C 55/07 (2006.01) , C07C 59/255 (2006.01) , C07D 207/12 (2006.01) | | Title | SALTE AF METHYL-6-(2,4-DICHLORPHENYL)-5-[4-[(3S)-1-(3-FLUORPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9-DIHYDRO-7H-BENZO[7]ANNULEN-2-CARBOXYLAT OG FREMGANGSMÅDE TIL FREMSTILLING DERAF | | Int. application no. | EP2019073823 | | Int. publication no. | WO2020049150 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
